ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 294530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 294530; 2) Community: the network communities that were significantly associated with the response to NSC 294530; 3) Molecule: the relationships between components within communities and NSC 294530; 4) MDR: the compounds that were significantly associated with the NSC 294530.

NSC Compound Enrichment Correlation
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0327254646997185 0.037007847
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0337307532806863 0.26937505
NSC 529108 4-Fluoro-D,L-tryptophan 0.0337307532806863 0.13741086
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0337307532806863 0.29290443
NSC 624401 Null 0.0337307532806863 -0.032947557
NSC 631451 Null 0.0337307532806863 0.11244201
NSC 638407 (E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate 0.0337307532806863 0.13058482
NSC 656204 Discorhabdin G 0.0337307532806863 0.059677893
NSC 657346 Null 0.0337307532806863 -0.02679606
NSC 661746 2-Debenzoyl-2-(3',5'-difluorobenzoyl)-15(16)-anhydro-11(15->1)-abeotaxol 0.0337307532806863 0.12036757
Total:33  Current:22    [First] [Prev] [Next] [Last]